{"name":"Saptalis Pharmaceuticals LLC","slug":"saptalis-pharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQUW9fY0tnX01XN0pvMXpQSTFZRklVb2dzejJvd2RBcDU5b2JIRjNIVUtjb1l3LS1obVh5eWtWdy03Q3VnSXcxZUFtOFJIdWh1ajYyVmNNbjVFdWtMcTh2VHpZeHU3YzVBWmd5TEFON2NoTzk1LU1VNnBhTnZ3Zi1BdXJwdUR6azhnREJBYnV1Y2lLRzdqdVRlQ0pMWmlOeDZ6a0xZUmxydmNJM2ZyMEF4ZHRXb1NobktXOWVoMWRmbDNPblNfbVQtVg?oc=5","date":"2025-06-18","type":"pipeline","source":"businesswire.com","summary":"Saptalis Pharmaceuticals Launches Fluoxetine Oral Solution, USP 20 mg/5 mL - businesswire.com","headline":"Saptalis Pharmaceuticals Launches Fluoxetine Oral Solution, USP 20 mg/5 mL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQZnViY3FaZzVPZVFueDhSYTB3SkJxUnRWREJiX2FqbVViOERtSG1XTUZjdVZoaVV0cXdXVVVFX1I5M1lMN3pHc1ZGN0R2V3BhRHJSYkdORWNWUWRHX2J3anV4V3Q4cjlud0tRYVRiVjlLbmJJZkZCelRHeUJ3Qk1yZUxBNzdUc1YtcG00M3VUckV6YnpyYkxjU1VtM1BuWjRCdW9VbmpRWkJicXI1LTFkaWlkejJJQmFzRUxQeC11QXRVLUl6MEJuQjJFQ0tsdXdhZ1RzZUZYZG5UMmk0YjNuMDN3dUlMbzYyRVFlcEtfNkk2UGN1UlRxTGNid0txcEpxei1CaDVFcHVsLXF5UXFyVEptWDlNT242WGJiS2NR?oc=5","date":"2025-05-20","type":"regulatory","source":"businesswire.com","summary":"— The First and Only US FDA-Approved Ready-to-Use Oral Suspension of Metronidazole - businesswire.com","headline":"— The First and Only US FDA-Approved Ready-to-Use Oral Suspension of Metronidazole","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQV2Mwbjg4d3haUmFXX0JJQWVFYXNCR3QyRWtlalZQeEQ0aFNaZlczdHN1MndwdEdvNmN3NGJub09ITmsyTEJxZWhKNWVWdG9VaVN5aUJ2OGIwamRDcWtaMDVWR3pxTUp1bEJfWU9FVFkzdm5iUjlpcmR2WjYwRnhPRlBINVJEcDV2V1lGanZnQUhsVklTZDdkLTk3cHR0YVpYbXd2Rzg5VWNlcFRyNl92ZDE5SnNxUmhJQTdxc1dpVUhEU21VUTRjUXQyTlF0SmpSX2J6WFFnVXNYZUFGbEZNOWFkSFgxLWxySlE?oc=5","date":"2023-11-14","type":"regulatory","source":"businesswire.com","summary":"Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ™ (metronidazole) Oral Suspension - businesswire.com","headline":"Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ™ (metronidazole) Oral Suspension","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOanBNN1VZXzhvYnhFbWRsc2hKX0dMMHdRMUVBaVJQZV9GX2oyVVg2TFZvSVJNXzhpSFk4TEgtdTVKMjQyaFFXbnlhN21wWDZLQUc5eVhxc3JPU0NWQjI4Z0pkS0lYc0R1TVpqb3FWLWRicUZyLVdCVXVQb0E3azlhTk5TSU91SjNJZUM3Z1FTWDVINnJHX3h1ZGhKS19jZVE?oc=5","date":"2020-05-15","type":"pipeline","source":"Pharmacy Business","summary":"Micro Labs and Saptalis launch metformin oral solution in US market - Pharmacy Business","headline":"Micro Labs and Saptalis launch metformin oral solution in US market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxQN1dVb0RadXVsOTZoeDg1Y1ZBTXVlUmVJRkZWYVUwMER6MWp5M0N6S2Y3RFN4UFpCZlFaUGFTU2ZIckFMV0N0VVJGNkwwYTZxX2ljelBLLWRYYUtIdENabDMtQ1g3Q3VZcklEdDl6b1ExQVZINExKTVJYakgxdjJjX1lIb2M5R1RTZDBhQkVuWnV4MzN1MFlZUmRsem9VQ0diaFp1S05xNXpWWXFMUmRnYkc5S2VQLU44VU16bFBBUDNDczlSTTA5SWtwcWFUR015N2tUOFhQWklnSVI2MWxyWk9qVGZWU3pvM2pRVkNlVU9HRThrNXVNLVpRVF9qV3lsVmx6MlpHMnRsMnRTbV9URVN3a0lsUjlhU3VTSklGcHB0UHM?oc=5","date":"2020-05-13","type":"pipeline","source":"prnewswire.com","summary":"Micro Labs USA Inc and Saptalis Pharmaceuticals LLC Announce Launch of Metformin Oral Solution (500 mg/5mL in two presentations 118mL and 473mL) - prnewswire.com","headline":"Micro Labs USA Inc and Saptalis Pharmaceuticals LLC Announce Launch of Metformin Oral Solution (500 mg/5mL in two presen","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}